STA-5326 Mesylate

STA-5326 mesylate · Synta Pharmaceuticals Corp.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for STA-5326 Mesylate, covering 2008-12-04 to 2017-07-02. Get the full timeline:

Most recent: Clinical Trial Update: The Immunological and Blood Effects of STA-5326 Mesylate on Patients With Crohn's Disease [Phase 2]